Genetic variants and haplotype analyses of the ZNF350 (ranked at 12) gene suggested that it is associated with high-risk non BRCA1/2 French Canadian breast and ovarian cancer families [31]. This evidence concerns the gene ZNF350 and ovarian cancer.